Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pred Forte vs placebo eye drops in chronic central serous chorioretinopathy (PICS)
2024-511575-15-00Phase 3Authorised
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Central Serous Chorioretinopathy (CSCR) comparing Pred Forte with Placebo (Duratears) (2 arms). Primary endpoint: Change in subretinal and intraretinal fluid on OCT. Planned start Jan 2025; status: authorised.
02
Drugs
prednisolone
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on 2024-511575-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511575-15-00.